The loss of functional RHAMY ablates signaling within focal adhesions, In particular changes in focal adhesion kinase phosphorylation, and as a result these focal adhesions are unable to turn over in response to hyaluronan.
Introduction
Extracellular matrix(ECM) molecules, their receptors, and gene products that modify the ECM are able to influence directly cell characteristics such as growth and motility (Ratner, 1992; Damsky and Werb, 1992; Hynes, 1992; Ruoslahti et al., 1994; Lin and Bissell, 1993; Jones et al., 1993) , to regulate cellular responses to growth factors and cytokines (Noble et al., 1993; Chong et al., 1992; Hiro et al., 1988) and to modify the transformed state. Many of these ECM receptors and their ligands can regulate the invasivelmetastatic phenotype in tumorigenic cells. Thus, overexpression of a481 integrin inhibits invasion during metastasis (Qian et al., 1994) while overexpression of the urokinase receptor enhances invasion (Kariko et al., 1993) . A regulator of metalloproteinases, TIMP-1, inhibits invasion of metastatic cells (Khokha et al., 1992; Alexander and Werb, 1992) . Other ECM receptors, however, partially modify the transformed state of cells. Thus, a581 "The first two authors contributed equally to this work.
integrins partially restore contact inhibition and anchorage-dependent growth properties of the tumorigenic CHO cells (Giancotti and Ruoslahti, 1990) , while overexpression of thrombospondin (Castle et al., 1993) results in the development of serum-independent growth. However, none of these ECM receptors has been frankly shown to be transforming.
The receptor for hyaluronan-mediated motility (RHAMM) signals elevated cell locomotion via a transient tyrosine phosphorylation within focal adhesions that results in their turnover in ras-transformed cells (Hall et al., 1994) . RHAMM is regulated by growth factors such as transforming growth factor pl (TGFPl) , and its expression is necessary for TGF81 stimulation of fibrosarcoma cell motility (Samuel et al., 1993) . We show here that, in contrast with other ECM receptors, overexpression of the hyaluronan (HA) receptor RHAMM (Hardwick et al., 1992 ) is both transforming and able to generate a metastatic phenotype, in which the subcutaneous tumors of RHAMM-transfected cells spontaneously metastasize, and these cells also form lung colonies after inoculation in the tail vein. The ability of RHAMM to transform fibroblasts indicates that this receptor functions in a fundamentally different manner than other characterized ECM receptors. In view of the elevated expression of RHAMM in r&s-transformed cells (Turley et al., 1991) and its importance in the locomotion of these cells (Hardwick et al., 1992) , we have also investigated the role of this receptor in ras transformation. We show here that disruption of RHAMM function by antisense RNA expression or by a dominant negative mutant of RHAMM profoundly reduces the transforming properties of the ras oncogene. We also link the ability of the dominant negative RHAMM mutation to ablate ras transformation to an effect on signaling via the focal adhesion kinase (FAK), ppl 25FAK, within focal adhesions.
Results

Overexpression of RHAMM in Fibroblasts induces Transformation
Since it had been previously shown that RHAMM expression was elevated in ras-transformed cells (Turley et al., 1991; Hardwick et al., 1992; Samuel et al., 1993 ) the contribution of RHAMM to the transformation process was investigated by its overexpression in nonsenescing fibroblasts. lOTl/z fibroblasts were transfected with either a genomic RHAMM clone, M (Hardwick et al., 1992; Entwistle et al., 1995) or a RHAMM cDNA encoding an isoform common to ms-transformed cells (RHAMM 1~4, Zhang et al., submitted) . Both transfections were chemically selected, and cell lines were cloned. Five clones that overexpressed RHAMM, as determined by Western blot analysis of cell lysates (Table 1) and Northern blot analysis of RHAMM RNA (data not shown), were selected from each transfection. These selected clones were further characterized, and their properties are summarized in Table 1 . Cells transfected with the RHAMM gene overexpressed a 73 kDa protein consistent with the predicted size of RHAMM (data not shown; Entwistle et al., 1995) . The same cells displayed an increase in a 4.2 kb message, the size of the major RHAMM mRNA transcript (data not shown; Hardwick et al., 1992) . The presence of the transfected RHAMM gene in all clones was confirmed by polymerase chain reaction (PCR) detection of plasmid arms (data not shown). The selected clones overexpressed products of the RHAMM gene at the cell surface as determined by fluorescence-activated cell sorter (FACS) analysis (Table  1) . Transfected cells appeared morphologically transformed (in that they were rounded), showed no evidence of contact inhibition, and possessed few focal adhesions (data not shown). Moreover, they exhibited a high nuclear overlap index comparable with that of ras-transformed cells (Table 1 ) and formed foci in monolayer culture, unlike the vector controls or the lOT% parent cell line (Table 1) . Furthermore, transfected cells reached culture confluence at a 3-fold to dfold higher ceil number relative to vector control or parent line controls (data not shown). The rate of random locomotion of the transfected cells was P-fold to 3-fold higher than control cell lines, a rate comparable with the ras-transformed C3 cell line (Table 1 ). This high motility was maintained at subconfluence and was blocked by anti-RHAMM antibodies (Table 1) . The rate of growth of RHAMM-transfected cell lines was less than that of rastransformed C3 cells and was, in fact, identical to that of the control cells until confluence halted growth of the latter. Nevertheless, RHAMM-transfected cells grew in an anchorage-independent fashion in soft agar (data not shown). Similar results on cell behavior were obtained after transfection of the RHAMM lv4 cDNA in a pHj3
APr-1-neo vector into lOTV2 or 3T3 fibroblasts (Table 1) . Transfection of RHAMM lv4 cDNA containing mutated HA-binding domains ( Figure 1 ) had no effect on morphology, contact inhibition, or motility (Table 1) .
To determine whether cells transfected with the RHAMM X4 gene were tumorigenic, we subcutaneously injected 1 x IV to 5 x 1 OB cells into the right hind leg of syngeneic mice. Fibrosarcomas formed within 3 weeks; no tumors formed in mice injected with vector-transfected or lOT% parental control cells (Table 1) . Tumors derived from the transfected cells were identical histologically to those formed byras-transformed cells and expressed high levels of RHAMM, as seen immunohistochemically.
Further, in approximately 50% of animals bearing subcutaneous tumors, tumors spontaneously metastasized to the lung to form a mean of five nodules per lung ( Table 1) . The occurrence of tumor cells within these nodules was confirmed by histology. Cells injected into mice via the tail vein invaded lung tissue and formed metastatic nodules (Table 1) . Cells transfected with RHAMM lv4 cDNA were also tumorigenic and metastatic, but cells expressing the mutated RHAMM 1~4, lacking HA-binding domains, were not (Table 1) .
These results were repeated with NIH 3T3 fibroblast cell line. We subcutaneously inoculated 5 x 10s transfected cells into syngeneic mice, and the presence of tumors was observed by 3 weeks ( RHAMM cDNA mutated at it8 HA-binding domains ( Figure  1 ). Similar suppressor mutations have been previously prepared by mutating the kinase domain (Evans et al., 1993) or by deleting the cytoplasmic domains of other receptors (Kashles et al., 1991) . The present approach to functional ablation was taken because RHAMM is secreted, is localized at the cell surface, and forms homodimers (Hardwick et al., 1992; Klewes et al., 1993) . Furthermore, mutation of the HA-binding domains in RHAMM destroys its ability to transform fibroblasts morphologically (Table 1) . Collectively, these conditions have been found to be sufficient to cdnstruct suppressor mutations of such growth-factor receptors as TGFPl (Brand et al., 1993) . The details of the amino acid substitutions in the HA-binding domains of RHAMM are outlined in Figure 1A . Loss of HA binding was confirmed using the mutated RHAMM fusion protein in a ligand blotting assay, the specificity of which has previously been demonstrated ( Figure 1A ; Hoare et al., 1993) . ras-transformed lOT% fibroblasts (termed C3) were transfected with the mutated RHAMM and chemically selected in hygromycin. Over 20 clones were selected, 25% of which displayed a flattened cell shape that was morphologically similar to 10TVz fibroblasts not transformed by ras ( Figure 2C ). Three clones containing the mutated RHAMM protein were selected for further analysis, and all three were found to overexpress RHAMM by 2.fold to 3-fold, as determined by Western blot analysis (for examples see Figure , 1992) which specifically recognizes a peptide encoded in the RHAMM cDNA (amino acids 268-289) that is 5' to the mutated region of the protein (see Figure 1C ). Despite their flattened morphology, all clones overexpressing mutant RHAMM exhibited levels of ~21"" protein that were comparable with or higher than those seen in the H-ras-transformed C3 fibrosarcoma cells transfected with vector only (see Figure 1 C ).
Despite the expression of high levels of activated ras, clones expressing the suppressor mutant of RHAMM (MR-C3-4D, MR-C3-58, and MR-C3-5C) more closely resembled the nontransformed lOT% cells in their growth characteristics, locomotion rates, and tumorigenic capabilities. Mutated RHAMM clones were contact inhibited and displayed a low nuclear overlap ratio, comparable with that of the nontransformed lOTlIz cell line (Figures 2A-2C ). They had a lower saturation density than ras-transformed vector control cells ( Figure 2D ) and showed suppressed ratesof locomotion in comparison with transformed parental C3 fibrosarcoma cell8 (Table 2 ). In contrast with vectortransfected controls, the cells expressing the dominant suppressor RHAMM failed to form foci in monolayer cultures ( Figure 2E ) and did not form colonies in soft agar (Table 2) . When injected subcutaneously into syngeneic mice, no tumors were detected after 6 months of observation ( Figure 2F ), while vector controls and the ras-lOT% parent cell line formed large tumors within 3 weeks ( Figure  2F ). In addition, the clones expressing mutated RHAMM did not develop tumors in the lung colonization assay for metastasis ( Figure 2G ). 
Expression
of Dominant Suppressor RHAMM Ablates Signal Transduction to Focal Adhesions We have previously shown that in ras-transformed fibroblasts RHAMM signals cell locomotion via a transient tyrosine phosphorylation pathway that targets focal adhesions (Hall et al., 1994) . Stimulation of these cells results in two rapid and transient events: tyrosine phosphorylation of several protein bands and the formation of focal adhesions. Net dephosphorylation and focal adhesion turnover rapidly follow concomitant with elevated cell motility. Since expression of the dominant suppressor RHAMM inhibits cell locomotion, among other transformationdependent processes (Table 2) we examined the effect of this protein on signal transduction and focal adhesions. Vector-transfected C3 cells responded to HA stimulation as previously reported (Hall et al., 1994) , with a transient increase in the phosphorylation of several protein bands (~185, ~125, ~115, and p85), followed by net dephosphorylation ( Figure  3A ). In particular, ~~125~~~ has been identified as a substrate in this pathway (Hall et al., 1994) . Transient tyrosine phosphorylation of this substrate, followed by dephosphorylation, coincidental with focal adhesion turnover, is observed in vector control cells (Figure 38 ). Tyrosine phosphorylation of FAK and other protein bands in the dominant suppressor-expressing cells (MR-C3-4D) remained constant over the stimulation time course (Figures 3A and  38) . Thus, ras-transformed fibroblasts expressing the dominant suppressor RHAMM cannot utilize the signal transduction pathway that involves changes in FAK phosphorylation and that is required for transformation by ras.
Cells possessing stable focal adhesions move more slowiy and are less tumorigenic (see Discussion). fastransformed fibroblasts normally have very few focal adhesions, but form temporary focal adhesions at the cell edge after HA stimulation (vector control, Figure 3Ca ). On the contrary, the cells expressing the HA binding-deficient RHAMM have numerous focal adhesions throughout the cell in the presence or absence of HA (Figure 3Cb ), thus resembling nontransformed lOTI/ fibroblasts. Similarly, tyrosine phosphotylation levels in these cells are higher and largely occur in the focal adhesions (Figure 3Cd ). The HA-stimulated vector control cells exhibit rapid onset of increased phosphotyrosine staining only at the lamellae edges and only at 1 min after stimulation with HA, while MR-CZUD were stimulated as described above for 1 min (lanes 2 and 5) or 15 min (lanes 3 and 6) with HA or with buffer alone (lanes 1 and 4) and then were lysed in RIPA buffer. Immunoprecipitation was performed with anti-FAK (lanes l-6) or mouse IgG control (lane 7), followed by SDS-polyacrylamide gel electrophoresis and anti-phosphotyrosine immunoblot analysis. Vector control fibroblasts (lanes 1-3) exhibit an increase followed by a decrease in FAK phosphorylation.
The MRC34D the MR-C3-4D cells do not respond to HA, but maintain high levels of plaque-like phosphotyrosine staining in the cell body and at the lamellae edges (Figure 3Cc and 3Cd) .
Antisense RHAMM Confers Resistance to Transformation
by Mutant H-MS To determine whether fibroblasts with suppressed RHAMM expression could be transformed with ras, we transfected lOT% cells with RHAMM cDNA in an antisense orientation. Two G418 resistant clones (termed OR1 and OR2) that expressed 100/o-50% of the detectable RHAMM protein levels seen in vector controls were selected from over Figure 2D ). 4C-4D). Furthermore, these clones, unlike ras-transformed controls, retained a flattened morphology. All rastransfected cultures expressed p21m* protein ( Figure 4E ) at levels similar to those of the ras-transformed cell line C3 (compare Figure 4E with Figure 1C ).
Discussion
We demonstrate here that the HA receptor RHAMM, a GPI-linked plasma membrane protein (L. Klewes et al., unpublished data), is not only transforming, but that its expression is sufficient to generate a metastatic fibrosarcoma. In addition, RHAMM also appears to be necessary for initiating and maintaining transformation induced by other oncogenes, such asras. Since ras-transformed cells expressing nonfunctional RHAMM are unable to signal and turn over focal adhesions, these results also imply a direct role for RHAMM in signaling within these cytoskeletal structures in the transformation process downstream of ras.
The transforming capability of RHAMM and the inability of RHAMM mutated in its HA-binding domains to transform cells demonstrate a causal role for HA in the transformation process. The observation that mutation of RHAMM in its HA-binding domains ablates fas transformation provides further evidence connecting HA to transformation. HA, a ubiquitous glycosaminoglycan, has previously been linked with both transformation and the metastatic process (Turley, 1992; Knudson and Knudson, 1993; Fraser and Laurent, 1993) , since it is often enriched in tumor-associated stroma (Turley and Tretiak, 1984) and its presence facilitates melanoma invasion across chorioallantoic membranes (Turley et al., 1987) . Highly metastatic tumor cells produce more HA (for review see Knudson and Knudson, 1993 ) and express higher levels of HA receptors (Gtinthert, 1993; Hynes, 1992; Hardwicket al., 1992) than less metastatic counterparts. Moreover, overexpression of one of the isoforms of the HA receptor CD44 increases primary and secondary tumor growth (Sy et al., 1991) a property that requires the HA-binding domain of this receptor (Bartolazzi et al., 1994) . As well, the V6 isoform of CD44 bestows a metastatic phenotype on transformed cells (Giinthert et al., 1991) , although it is not known whether this property is dependent upon the HA-binding capability of this &form.
As noted in the introduction, other ECM receptors and ECM molecules (Hynes, 1992; Gtinthert et al., 1991; Stetler-Stevenson et al., 1993; Schwartz, 1993; Behrend et al., 1994) have also been linked to the regulation of the invasive properties of cells or to the partial modification of the transformation process itself. It is important to note, however, that none of these molecules has been demonstrated to be transforming by itself, implying that RHAMM has a unique role in orchestrating events that are essential for transformation to occur. These events include the ability of RHAMM to signal, via focal adhesions, alterations in the cytoskeleton and elevated cell locomotion.
Focal adhesions are sites of ECM receptor-cytoskeletal interactions, where second-messenger signaling commonly occurs in response to the ECM and some growth factor receptors. These structures, also described as signal transduction units (Lo and Chen, 1994; Zachary and Rozengurt, 1992 ) are believed to be critical for the regulation of growth and cell motility (Woods and Couchman, 1988; Burridge et al., 1988) . They have previously been linked to transformation, in that very few focal adhesions are present in tumor cells (Burridge et al., 1988) and focal adhesion assembly promoted by overexpression of the focal adhesion components, a581 integrin, tensin, or vinculin, causes partial reversal of transformation (Giancotti and Ruoslahti, 1998; Varner et al., 1992; Lo and Chen, 1994) . Conversely, antisense ablated expression of the focal adhesion protein vinculin promotes transformationdependent properties (Rodriguez-Fernandez et al., 1993) ; as well, the selective targeting of truncated v-src to focal adhesions, but not to the nucleus or to the cytoplasm, is sufficient for transformation by this oncogene (Leibl and Martin, 1992) . We have previously noted that in rastransformed fibroblasts, unlike their parental counterparts, HA regulates cell motility via RHAMM by signaling transient protein-tyrosine phosphorylation within focal adhesions (Hall et al., 1994) . In this signaling pathway, FAK is transiently phosphorylated, followed by net dephosphorylation and focal adhesion turnover leading to the initiation of cell locomotion (Hall et al., 1994) . Cells overexpressing RHAMM resemble ras-transformed fibroblasts and have elevated cell locomotion and focal adhesion loss, as well as tumorigenic and metastatic potential. Conversely, expression of a dominant suppressor mutant of RHAMM reverts transformation induced by fas and stabilizes focal adhesions (X. Y. et al., unpublished data). This HA receptor targets focal adhesions and likely acts downstream of ras or via a parallel pathway that converges at the level of ras.
FAK has been implicated in several signaling pathways that involve ECM receptors, as well as in transformation (Schaller et al., 1992; Calalb et al., 1994) . The stimulation of activation by growth factors, neuropeptides, and the ECM is associated with cell attachment, focal adhesion assembly, and stress fiber formation (Schaller and Parsons, 1994; Zachary and Rozengurt, 1992) . Cell adhesion via in&grins can stimulate the formation of signaling complexes containing FAK, c-src, Grb-2, and Sos (Schlaepfer et al., 1994) thus providing a mechanism for the regulation of the ras/MAP kinase signaling cascade downstream of FAK phosphorylation.
On the contrary, transient FAK phosphorylation, followed by net FAK dephosphorylation, has been associated with elevated cell migration (Hall et al., 1994; Matsumoto et al., 1994) and, hence, may represent the mechanism by which ras and RHAMM regulate elevated cell motility. We show here that a dominant suppressor mutation of RHAMM that ablates ras transformation collectively prevents HA binding, HA-triggered FAK signaling, focal adhesion turnover, and cell motility. Thus, while integrin and growth factor-regulated FAK phosphorylation would appear to be upstream of ras signaling, our results indicate that FAK dephosphorylation, regulated by RHAMM, acts downstream of mutant ras and is an event that is required for transformation by this oncogene. While our results specifically suggest that the constitutive ability to turn over focal adhesions is a requirement for ras transformation, this event by itself is unlikely to be sufficient for transformation to occur. Hence, the overexpression of either of the ECM components, thrombospondin or tenastin, reduces focal adhesion assembly (Borsi et al., 1992; Murphy-Ullrich and Hook, 1989) , but both are only partially transforming, merely enhancing serum-and anchorageindependent growth of immortalized cell lines (Castle et al., 1993; Murphy-Ullrich et al., 1991; Wehrle-Haller and Chiquet, 1993) . Also, loss of focal adhesions induced by the overexpression of a truncated rasGAP has little effect on growth potential (McGlade et al., 1993) . The regulation of focal adhesion turnover, probably effected by dephosphorylation of FAK, is likely required for transformation to occur, but is unlikely to account for !he tumorigenicl metastatic properties. Thus, overexpression of RHAMM must result in transformation by altering additional cell characteristics.
Signaling via tyrosine phosphorylation has previously been identified as an event that can lead to transformation, and since RHAMM transiently activates protein phosphorylation, such signaling may ultimately lead not only to focal adhesion turnover, but also to selective expression of genes that act collectively through ras to transform the cell. Previous reports link signal transduction pathways mediated by other ECM receptors (Damsky and Werb, 1992; Hynes, 1992; Juliano and Haskill, 1993; Schwartz, 1993) to changes in gene expression (Jones et al., 1993) . Mammary epithelial cells produce tissue-specific proteins in response to basement membranes (Howlett and Bissell, 1993) , while laminin, fibronectin, and other ECM components regulate stromelysin, collagenase (Werb et al., 1989; Shapiro et al., 1993; Saarialho-Kere et al., 1993) , and other genes (Jones et al., 1993) . HA has also previously been reported to regulate the expression of several cytokinegenes, in partviaCD44 (Nobleet al., 1993; Chong et al., 1992) . It is likely therefore that other genes are also regulated by RHAMM.
Insummary, wahavedemonstrated thatoverexpression of RHAMM is transforming and that ablation of RHAMM expression or its function prevents ras transformation. We also provide direct evidence of a role for signaling within focal adhesions for maintaining ras transformation.
Experimental Procedures
Cell Culture and Cell Lines The previously established murine fibroblast cell lines lOT%, NIH 3T3, and the H-ras-lOT1/?: CIRAS-3 (C3; Egan et al., 1987) were utilized for the various transfection and tumorigenic studies. The cells were maintained at 37OC in 5% CO* in DMEM growth media (GIBCO BRL) supplemented with 10% fetal calf serum (Invitrogen). Cells were subcultured using trypsin and EDTA (0.25% Difco bactottypsin, 2 mM EDTA) prior to reaching confluence.
To determine culture density, we added 5 x lOa cells to each of 24 wells in 1 ml of DMEM supplemented with 10% FCS and 0.6 mg/ml geneticin. Medium was changed every 3 days, and at each timepoint cells were released from the substratum with 0.25% trypsin and counted with a Coulter counter.
Preparation
of DNA Constructs The full-length RHAMM gene was isolated from a 3T3 cell genomic library and is describedelsewhere (Enhvistleet al., 1995) . Thegenomic RHAMM clone 14 was harbored in EMBWphage armsfortransfection. RHAMM cDNAs, mutated cDNAs, and antisense cDNAs (Hardwick et al., 1992; Entwistle et al., 1995) were cloned into the pHP APr-1-neo expression vector (Gunning et al., 1987) . The cDNAs mutated in their HA-binding domains have been described previously (Yang et al., 1994) . In brief, mutagenesis of specific basic amino acids in both of the HA-binding domains of RHAMM was accomplished in two steps. First, site-directed mutations were confined to basic amino acids Lys-405 and Lys-409. Next, the basic amino acids 430 and 432 were mutated using the RHAMM cDNA generated in the first step. The mutations abolish HA binding of the resulting protein (Figure 1 ; Yang et al., 1994) . The RHAMM antisense cDNA was produced by PCR of the entire coding region (amino acids l-477; Hardwick et al., 1992) and 172 ntof the S'flanking sequence. The fragment cloned into the expression vector in the antisense orientation was sequenced for confirmation.
Transfection
with Genomic RHAMM In RHAMM cDNAs The RHAMM M clone in EMBW phage arms was cotransfected with PSV, plasmid into lOT% fibroblasts using calcium phosphate. RHAMM-transfected cells were selectively grown in growth media containing 0.6 mglmlG418 for 3 weeks, colonies were cloned by selective trypsinization, and 15 clones were isolated. Four clones (14-2-lOTl/z, X4-6-lOTM, 14-lo-IOTX?, and 14-12-lOTl/z) that exhibited stable integration of the RHAMM gene by Southern blot analysis and overexpression of the RHAMM protein by immunoblot analysis were selected for further study.
lOT'/z and NIH 3T3 cell lines were transfected with either the RHAMM Iv4cDNA construct (Entwistle et al., 1995; S. 2. et al., unpublished data) in the pHp Apr-I-neo expression vector (Gunning et al., 1987) orthe RHAMM lv4cDNAmutatedconstructasdescribedabove. To produce stably transfected cell lines, we transfected fibroblasts using lipofectin (GIBCO BRL) according to the instructionsof the manufacturer, and cells were selected in G418. Clones were then selected as above and tested for overexpression using Western blot analysis (S. Z. et al., unpublished data) . Based on their overexpression and representative morphology, the following clones were used in this study: vector-transfected cells, RHAMM Iv4-overexpressing clones (cDNA 5-lOT1/2 and cDNA-3T3), and a mutated RHAMM lv4 clone (MR-lOTM-4).
For dominant negative transfections, C3 cells were stably transfected with the mutated RHAMM cDNAs as described above, except that the hygromycin gene was included in the pHp APr-I-neo vector. Cells were selected in hygromycin and geneticin (to maintain ras insert) and then cloned. Clones that exhibited a flattened morphology (45% of clones) were selected and then analyzed for overexpression of RHAMM using a Western transblot assay. Three high expressing clones were selected.
RHAMM cDNA (Hardwick et al., 1992) was used as a PCR template to generate a 1.7 kb fragment containing the entire coding region (amino acids l-477) and 172 nt of 3'flanking sequence. The fragment was cloned in an antisense orientation into the pHb Apr-I-neo expression vector (Gunning et al., 1987) and sequenced for confirmation. To produce stably transfected cell lines, we transfected lOTl/z fibroblasts using lipofectin with RHAMM antisense plasmid constructs according to the instructions of the manufacturer (GIBCO BRL). In brief, 1 x 105 to 2 x IoSof the lOTl/z cells were seeded into 60 mm tissue culture dishes and cultured in growth medium containing DMEM and 10% fetal bovine serum. After reaching 50%-70% confluence, cells were transfected with 1 O-20 pg of RHAMM plasmid, selected in G418, and then cloned. Low production of RHAMM was detected by Western blot analysis and RI-PCR.
Cell Lysie and lmmunoblot Analysis C3 cell cultures were exposed to HA (10 nglml; Hall et al., 1994) , 1994) for 2 hr at room temperature on a rotator (Nutator, Becton Dickinson). The membranes were washed four times in 0.05% Tween 20 in TBS before incubation with peroxidawoonjugated goat anti-mouse secondary antibody (I:5000 dilution in 1% milk and Tween 20 in TBS; Sigma) for 1 hr at room temperature.
After washing, blotsweredeveloped using the ECLWestern blotting detection system (Amersham) according to the instructions of the manufacturer.
To establish antibody specificity, we probed parallel blots with anti-phosphotyrosine that had been preincubated with 200 pM phosphotyrosine (Sigma) for 1 hr. Likewise, anti-RHAMM antibodies were preincubated with 200 pg of RHAMM fusion protein before incubation with membranes as above.
lmmunopreclpltatlon Cells were stimulated with HA and lysed as described above. Each sample (500 ug of protein) was incubated with anti-p125FU MAb (4 &ml monoclonal anti-FAK; Transduction Laboratories) and rabbit anti-mouse IgG (10 &ml; Sigma) for 1 hr at 4OC by mixing end-overend. To cause precipitation, we added 100 pl of protein G-agarose (GIBCO BRL) to each tube, and the samples were mixed end-over-end for another 30 min at 4OC. The beads were pelleted by brief centrifugation at 13,OGJ rpm and washed three times with RIPA buffer. The proteins were released from the beads by boiling in Laemmli sample buffer and were then subjected to SDS-PAGE and anti-phosphotyrosine immunoblotting as described above. To assess whether equal quantities of FAK were immunoprecipitated from control and treated samples, the blots were stripped and reprobed with purified anti-FAK antibody 2A7 (10 us/ml; a gift from J. T. Parsons).
Immunofluoreecent Stalnlng
Vector control ras-lOTH, MR-C3-4D, and MR-C3-5C fibroblasts were grown on untreated or fibronectin-coated glass coverslips for 24 hr. The cells were exposed to HA (10 @ml), anti-RHAMM, or control treatment for 1 min and 15 min. At the appropriate time periods, the media was aspirated, and the cells were rinsed with PBS and then fixed with 3% paraformaldehyde (Sigma) in PBS for 10 min. Cells were washed three times for 10 min with wash solution (10% FCS in PBS containing 0.02% sodium azide), permeabilixed with 0.2% Triton X-100 in PBS for 5 min, and washed three more times. The fixed cells were incubated at 37*C for 1 hr with anti-phosphotyrosine MAb 4610 (5 @ml; Upstate Biotechnology), anti-vinculin MAb (1:50, Sigma), or appropriate IgG controls (Sigma) in wash solution. After being washed five times, coverslips were incubated with goat anti-mouse Cy3 (1500; Jackson) for 3 hr. After washing, the coverslips were mounted onto glass slides using Fluoromount (BDH). Observations and photomicrographs were obtained with a Zeiss Axiovert 35x fluorescent microscope using epifluorescence.
Time-Lapse Clncmlcrogrephy
To monitor random locomotion, we plated 6 x 10' cells in 25 cm2 tissue culture flasks 24 hr prior to measurement.
Cell locomotion was quantified using an IM 35 inverted microscope (Zeiss), to which a video camera (Hamamatsu CCD) was attached. The cells were maintained at 37OC using a heated platform (TRZ 3700, Zeiss). Motility was measured using image analysis (Image 1, Universal Imaging). This program allows quantitation of nuclear displacement in a sequence of digitalized images.
Flow Cytometry
Cells were harvested using Hanks' balanced salt solution plus 20 mM HEPES, 0.05% sodium azide, and 2.0 mM EDTA for 5 min and were maintained at 4OC throughout the procedure. The cells were washed in the same solution except in the absence of EDTA and then incubated with anti-peptide (amino acids266-266)antiserum (15Odilution; Hardwick et al., 1992) for 30 min. Following this, the cells were incubated with ftuoresceinconjugated goat anti-rabbit antiserum (1300 dilution; Sigma) for a further 30 min and were then fixed with 3% paraformalde hyde. The surface expression of RHAMM was studied using immune fluorescence flow cytometry. Normal IgG was used as a control at each timepoint analyzed.
HA Blnding Aeeey
Proteins were electrophoresed on 10% SDS-polyacrylamide gel and transbfotted onto a nitrocellulose membrane in a Tris-glycine buffer containing 25 mM Tris, 192 mM glycine, and 20% methanol (pH 6.3) at 60 V for 1 hr in a cold room. The membrane was blocked in IO mM Tris-HCI (pH 6.0) containing 150 mM NaCl (TBS), 0.05% Tween 20 (TBST), and 5% skim milk powder (TBSTS) for 1 hr at room temperature and then incubated with biotinylated HA (Yang et al., 1994) and diluted in TBSTS (12000) overnight at 4OC. The membrane was washed with TBST extensively and then incubated with astreptavidinperoxidase conjugate in TBSTS. Binding was visualized with chemiluminescence according to the instructions of the kit (ECL Kit, Amersham), which uses luminal and hydrogen peroxide to visualize the bound peroxidase.
Focus Formatlon
Cells were grown to 50% confluence and, in the case of RHAMM antisense-transfected clones, transfected with H-ras using lipofectin as described above or, in the case of RHAMM sense-transfected clones, buffer only. The cultures were then grown for 3-4 weeks in DMEM medium containing lo%-20% FBS. The medium waschanged every 1-3 days for up to 4 weeks until foci formed. Foci were visualized with methylene blue staining and were counted per dish.
Growth
In Soft Agar
We plated 5 x 1 OS cells per milliliter in bactoagar (1.25%) containing anti-MEM, 10% FBS for 7-10 days. Colonies of cells were counted per plate. The plating efficiency of each cell line was similar (75%).
Subcutaneous
Tumor Formetion and Tall Vein Aeeay Cells were grown to confluence, washed with Hanks' solution and released from the substratum in Hanks solution containing 2.5 mM EDTA. If cells did not release (i.e., lOTI,+ cells), they were scraped from the substratum with a rubber poficeman. Excfusion of trypan blue indiceted that >90% of cells treated in this manner were viable. C3 femalemicewereinjectedwith 1 x 10105 x 1Oceflssubcutaneousty into the right hind leg and maintained for 3-6 weeks, when tumors routinely become apparent. Animals were euthanized, tumors were removed and weighed, and pieces were processed for histology using paraffin embedding techniques. Lungs were also excised and examined for tumor nodules, which, when present, were also processed for paraffin sections.
For experimental metastasis assays (Egan et al., 1967) , 5 x Iv cells were injected into the tail vein. The mice were maintained for 6 weeks and then euthanized, lungs were removed, and the occurrence of tumor nodules was 859898Bd by processing tissue for histology and examining tissue sections for tumor nodules. 
